Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$6.18 - $14.44 $3.36 Million - $7.85 Million
-543,470 Closed
0 $0
Q4 2021

Feb 08, 2022

BUY
$7.8 - $14.38 $1.44 Million - $2.66 Million
185,124 Added 51.66%
543,470 $7.72 Million
Q3 2021

Nov 12, 2021

BUY
$7.76 - $29.37 $323,824 - $1.23 Million
41,730 Added 13.18%
358,346 $2.87 Million
Q1 2021

May 12, 2021

BUY
$11.61 - $32.08 $3.68 Million - $10.2 Million
316,616 New
316,616 $9.2 Million

Others Institutions Holding EPIX

About ESSA Pharma Inc.


  • Ticker EPIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,073,100
  • Market Cap $71M
  • Description
  • ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...
More about EPIX
Track This Portfolio

Track Frazier Management LLC Portfolio

Follow Frazier Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frazier Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frazier Management LLC with notifications on news.